Archives: Speakers

Brian Coventry, CEO of CloudCapcha and Symphony – APS ., is an expert at helping professional service firms be more effective, using software and consulting techniques to improve and grow business value. He helps firms with selecting and implementing software platforms that are focused on client transformation and linked to operational goals and strategic objectives.

Brian’s experience and knowledge of business, strategy and management – gained from different countries and cultures – helps others see a forward path, revealing options and value improvements. His ability to communicate highly technical concepts in a way that makes it easy for others to understand is essential for bringing teams into a discussion on change, helping them define solutions, and working to make them a reality.

He possesses strong leadership and communication skills and has gained a reputation for building cohesive high-performing teams through his people-orientation and leading by example. He maintains a strong adherence to principles, values and beliefs while focusing on and achieving results. Brian is regarded as an honest and candid leader; he is able to focus on issues and is comfortable making the hard decisions within a business.

Brian earned a Bachelor of Business, Accounting degree from Deakin University in Australia.

Callie is the founder of KaliKare, a cannabis infused topicals company. She has been a cannabis user for over 40 years. In the last 5 years she has been working with an formulator, to produce helpful natural cannabis infused body care products. She is passionate about building a successful brand and helping customers understand how they can self medicate using topicals!

Dr. Greg Maguire is founder and CEO of BioRegenerative Sciences, Inc. (bioregenerativesciences.com), a privately held stem cell therapeutics company in San Diego, and The SRM Living Foundry at UCSD (http://srmfoundry.org), a public-private venture at UCSD serving as a stem cell-based “living foundry” for the development of therapeutics, antimicrobials, nano-delivery systems, and bio-inspired building blocks for materials science and engineering. Dr. Maguire has been professor at UCSD, The University of Washington, and The University of Texas, a Fulbright-Fogarty Fellow, and his research, with over 100 publications, has been sponsored by the NIH and NSF. He is the founder of several biotech and pharmaceutical companies, and non-profits, including The San Diego Neuroscience Group, and currently serves on the Board of Nurture Earth (NE), a spin-out of MIT in Aurangabad, India. NE is a private company for the development of alternative/renewable energy, food, and healthcare technologies and products.

Dr. Maguire’s research and development efforts are focused on the use of stem cell released molecules (SRM) for therapeutic and technical innovation in the life sciences and materials sciences. Because SRM provides up to 80% of the therapeutic benefit of stem cell therapy, and because SRM provides the building blocks for life and the “instruction set” for the architecture of life, Maguire has begun to reverse engineer stem cell SRM processes in the human body, and other life forms. The results thus far include “systems therapeutics,” the most efficacious technology and products for wound healing, anti-scarring, skin care, dry eye, and cataract. The S2RM platform technology developed at BRS also has demonstrated value in cancer, immune disease, and cognitive therapeutics.

Mr. Solis is a recognized expert in FDA import operations who has served as the acting assistant
commissioner and director of ORA’s Office of Enforcement and Import Operations (OEIO) since
March 29, 2020. During this time, he has provided leadership and direction to all OEIO field
import divisions as well as the Division of Food Defense Targeting and Division of Import
Operations at FDA HQ. He brought about the leadership and stability needed during the
COVID-19 Pandemic. Mr. Solis was selected as the Assistant Commissioner for Import
Operations on November 22, 2020 and prior to that he was the Division Director for the Division
of West Coast Imports since February 9, 2018.

He started his career with FDA in 1998. Prior to working in FDA, Mr. Solis worked in the
Bioresearch field focusing on Medical Device and Drug Application Products after graduating
from the University California of Irvine and the University of La Verne. Mr. Solis has held many
positions within FDA that includes working at the FDA lab in Irvine, Ca. as a Microbiologist,
HQ position within the Division of Import Operations in Rockville, MD, working as an Import
Compliance Officer and working in the FDA Los Angeles District Office as a Director of Import
Operations Branch.

Mr. Solis is an experienced collaborator who has played an integral role in FDA operational
activities with other federal agencies, partnering with Customs and Border Protection,
Homeland Security Investigations, U.S. Department of Agriculture, U.S. Fish and Wildlife
Service, Drug Enforcement Agency, and state and local law enforcement agencies. Additionally,
he conducts local and national training on imports, is a member of the National Leadership
Development Workgroup at FDA’s Office of Training and Education Development, and has
served as a mentor for the Federal Executive Board in Los Angeles and ORA’s Potential
Supervisors Program.

In his new role, Mr. Solis serves as the principal advisor to Associate Commissioner for
Regulatory Affairs and report to the Deputy Associate Commissioner for Regulatory Affairs
(DACRA) on all import matters. This includes providing direction and oversight to FDA field
import operations, reviewing prior notice and intelligence data on human and animal food, and
leading the development and implementation of new import programs and procedures.
Mr. Solis has had many accomplishments within FDA and these are a few notables:
Implementation of PREDICT at all ports in the US, the implementation of electronic
communications and paperless transactions initiatives with the Trade Associations, formation of
the CBP/FDA Teams including the Opioid Task Force, formation of the West Coast Import
Advisory Council, formation of Federal and State Task Forces, conducting Federal Operations,
streamlining the refusal process in the Ports of LA, San Francisco and Seattle, and development
of strong partnerships with the filers, brokers and importers in the Pacific Region.

Mr. Solis is nationally recognized as a subject matter expert in the program area of Import
Operations and gives local, as well as, national training on Imports Investigations. He is a
member of the National Leadership Development Workgroup at FDA’s Office of Training and
Education Development, has served as a mentor for the Federal Executive Board in Los Angeles
and the Potential Supervisor Program within FDA. He also has had integral roles in FDA
Operations with other Federal Agencies, working with CBP, HSI, USDA, FWS, DEA and State
and local law enforcement agencies. Currently, aside from his duties at the port, Mr. Solis is also
a member of the FSMA – Foreign Supplier Verification Program (FSVP) Implementation Team
as well as the Associate Commissioner’s IT Advisory Workgroup, the Associate Commissioner’s
Import Advisory Panel, member of AFDO, WAFDO, ASQ, OCRA and the Pacific Island Health
Officers Association (PIHOA).

Mr. Solis holds a Masters Degree (MS) in Healthcare Administration from the University of
LaVerne and a Bachelor’s Degree (BS) from University California of Irvine.

Dr. Hsu is anesthesiologist and pain management physician, but also a serial entrepreneur. His most recent activity is as CEO and Founder of QuiVivePharma, a company he took from inception to a FDA face-to-face PreIND meeting in just 1 year.

He is also President of SBS Medical Management, a healthcare economic consulting firm for investment banks and Expert Medical Reviews, including the California Medical Board.

Other companies he has founded or co-founded include: 1) IMTH, a real estate investment trust with properties through the state of California; 2) iPill Dispenser, a medical device that uses a mobile app to control a secure, stand-alone pill dispenser to prevent opioid sharing, diversion, and drug overdoses; and 3) NAOMI systems, a practice management software company that integrates digital X-rays devices in PACS, EMR and RCM billing modules.

After years of watching the opioid crisis develop, John has developed an innovative drug and dispenser to safely treat pain and deter abuse.  His drive to improve healthcare is based on passion, compassion and hope.